New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella
NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / New to The Street, the nation's leading financial television series, announces the nationwide broadcast of Episode #673 on Saturday, June 21 at 6:30 PM EST across Bloomberg Television as sponsored programming.
Sponsored by The Sustainable Green Team's (OTC PINK:SGTM) Waterless Garden, this week's show features five innovators from across the Web3, biotech, ETF, insurtech, and wellness industries. The program includes exclusive coverage of FLOKI's June 30 mainnet launch of Valhalla, one of the most anticipated metaverse game deployments in crypto.
In addition to its national TV footprint, New to The Street also delivers major reach via its rapidly growing YouTube platform, New to The Street TV, which now has over 2.77 million subscribers and features full interviews and behind-the-scenes content:YouTube.com/@NewToTheStreetTV
Featured Segments Include:
FLOKI - The people's crypto shares key updates including the June 30 launch of Valhalla, its Norse mythology-based metaverse game, and continued growth of its no-code tokenization platform, TokenFi.NRX Pharmaceuticals (NASDAQ:NRXP) - CEO Dr. Jonathan Javitt discusses progress on the company's FDA-designated drug candidates and its national rollout of interventional mental health services through HOPE Therapeutics.MUSQ - The Music ETF (NYSE:MUSQ) - The only ETF focused entirely on the music industry, MUSQ delivers a new opportunity for investors to gain exposure to global music revenues.Health In Tech (NASDAQ:HIT) - The insurtech company digitizing benefits through real-time quoting, advanced APIs, and simplified plan management.Vita Bella - A wellness brand combining science-based skincare and nutrition for a premium, longevity-focused lifestyle product suite.
New to The Street airs weekly on Bloomberg Television (Saturdays at 6:30 PM EST) and FOX Business (Mondays at 10:30 PM EST), reaching over 225 million homes and backed by outdoor Times Square billboards, earned media placement on ABC/NBC/CBS affiliates, and one of the fastest-growing business YouTube channels in the industry.
About the Featured Companies
About FLOKI
FLOKI is the people's cryptocurrency and the utility token of the Floki Ecosystem, with over 550,000 holders worldwide. Built around utility, community, philanthropy, and marketing, FLOKI has launched campaigns seen by billions. The upcoming June 30, 2025 mainnet launch of Valhalla, its metaverse MMORPG, marks a milestone in its global roadmap.floki.com | @RealFlokiInu
About TokenFi
TokenFi is a no-code platform empowering users to create and tokenize crypto and real-world assets with ease, targeting the multi-trillion-dollar asset tokenization industry.tokenfi.com | @tokenfi
About Valhalla
Valhalla is FLOKI's metaverse MMORPG where users explore, collect, and battle creatures called Veras in a decentralized, play-to-earn economy. The mainnet goes live June 30, 2025.valhalla.game
About NRX Pharmaceuticals, Inc. (NASDAQ:NRXP)
NRX Pharmaceuticals is developing NMDA-targeted therapeutics to treat CNS conditions including suicidal bipolar depression, PTSD, and chronic pain. Its lead drug, NRX-101, has FDA Breakthrough Therapy Designation and is moving toward accelerated approval. The company is also advancing NRX-100, a preservative-free ketamine formulation with Fast Track Designation.nrxpharma.com
About HOPE Therapeutics, Inc.
HOPE Therapeutics, a subsidiary of NRX Pharmaceuticals, is establishing a national network of clinics to deliver ketamine, TMS, and digital therapies for patients with suicidal depression and related disorders.hopetherapeutics.com
About MUSQ - The Music ETF (NYSE:MUSQ)
MUSQ offers diversified exposure to the global music economy, including streaming platforms, music publishers, labels, and live event companies-all in one ETF.musqetf.com
About Health In Tech (NASDAQ:HIT)
Health In Tech is a disruptive insurtech streamlining plan administration through real-time quoting tools, automation, and API-driven integration.healthintech.com
About Vita Bella
Vita Bella is a premium wellness and skincare brand blending science and beauty through clean, longevity-driven formulations for skin and body health.vitabella.com
About The Sustainable Green Team (OTC:SGTM)
The Sustainable Green Team is an industry leader in environmentally responsible solutions. Its Waterless Garden system redefines landscaping through sustainable, soil-enhancing mulch that requires no irrigation-backed by proprietary soil tech and adopted across eco-conscious public and private developments.thesustainablegreenteam.com
Media Contact:Monica BrennanDirector of Media RelationsMonica@NewToTheStreet.com
Explore more: www.NewToTheStreet.comWatch on YouTube (2.77M+ subscribers): YouTube.com/@NewToTheStreetTV
SOURCE: New To The Street
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?
We recently published . Paramount Skydance Corp. (NASDAQ:PSKY) is one of the best-performing stocks on Wednesday. Paramount Skydance extended its rally to touch a new high on Wednesday, finishing up by 36.74 percent at $15 apiece, with a former hedge fund manager calling it a 'meme' stock. In a social media post, Mad Money host and former hedge fund manager Jim Cramer said Paramount Skydance Corp. (NASDAQ:PSKY) is a 'meme stock' given the company's small public float and unjustifiable rally amid the lack of fresh developments. Paramount Skydance Corp. (NASDAQ:PSKY) climbed by as high as 60 percent at intra-day trading to hit $17.53 before paring gains to finish slightly lower during the session. In recent news, the company bagged a new $7.7-billion deal to exclusively air the Ultimate Fighting Championship (UFC) on Paramount+ for seven years beginning in 2026. The deal would include UFC's full slate of 13 marquee numbered events and 30 Fight Nights through its direct-to-consumer streaming platform, Paramount+, with select numbered events to be simulcast on CBS. cellanr, CC BY-SA 2.0 , via Wikimedia Commons As part of the agreement, Paramount Skydance Corp. (NASDAQ:PSKY) will move UFC away from the existing Pay-Per-View model and make the latter available at no additional cost to Paramount+ subscribers in the US. It also intends to explore UFC rights outside the US in the future. While we acknowledge the potential of PSKY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a minute ago
- Yahoo
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a minute ago
- Yahoo
Why TeraWulf Stock Is Skyrocketing Today
Key Points TeraWulf inked a multiyear, multibillion-dollar agreement to provide up to 200 megawatts of compute power to an AI cloud provider. The deal will be backed by Google in exchange for a potential 8% stake in TeraWulf. 10 stocks we like better than TeraWulf › Shares of TeraWulf (NASDAQ: WULF) are flying on Thursday, up 44.1% as of 1:09 p.m. ET. The jump comes as the S&P 500 and Nasdaq Composite were down slightly. TeraWulf, a Bitcoin miner and high-performance computing (HPC) data center company, announced it inked a 10-year, $3.7 billion deal backed by Alphabet's Google. TeraWulf signs a massive deal for AI data center space Along with releasing its second-quarter earnings, TeraWulf announced a major co-location deal with Fluidstack, an artificial intelligence (AI) cloud provider that will see the company provide 200 megawatts of compute power at its data center in New York. The 10-year, $3.7 billion deal has the option to be extended twice for up to a total of $8.7 billion. Google will guarantee up to $1.8 billion if Fluidstack fails to make good on its lease obligations. In exchange, Google will be awarded warrants for 41 million shares of TeraWulf, about an 8% stake. The guarantee will allow TeraWulf to access the financing it needs to provide the 200 megawatts of compute power. TeraWulf stock is hot, but investors should exercise caution This is the latest major data center deal as big tech races to build enough capacity to meet current and projected future demands. It's hard to overstate just the scale of the efforts. Google, Amazon, Microsoft, and Meta Platforms alone are expected to spend roughly $400 billion next year and are on track to spend more than $350 billion this year. That's not total capital expenditures (capex), that is specifically data center capex. While this presents an enormous opportunity for data center providers, it also presents an enormous risk. I believe that the big tech companies are very purposefully making deals such as this one to offload the risk onto third parties. TeraWulf and other infrastructure companies like it are taking on enormous amounts of debt at very high interest rates. If there is an overbuild or AI demand sags, TeraWulf could find itself in a pretty precarious position. Should you invest $1,000 in TeraWulf right now? Before you buy stock in TeraWulf, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TeraWulf wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, and Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Why TeraWulf Stock Is Skyrocketing Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
